It is worth noting that a previous report that investigated the functions of non-receptor GEFs in metastatic colorectal cancer found that NUCB1 overexpression was correlated with shorter progression-free survival (PFS) (Barbazan et al., 2016). Here, NUCB1 is linked to metastatic colorectal cancer.